Nevertheless, Lynch syndrome modestly increases bladder cancer risk; recent reviews estimate ~12% cumulative risk by age 70 in male MSH2 carriers—higher than population norms [55,59]. This evidence concerns the gene MSH2 and urinary bladder cancer.